BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10525384)

  • 21. Mandatory second opinion in surgical pathology referral material: clinical consequences of major disagreements.
    Manion E; Cohen MB; Weydert J
    Am J Surg Pathol; 2008 May; 32(5):732-7. PubMed ID: 18360282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mandatory second opinion surgical pathology at a large referral hospital.
    Kronz JD; Westra WH; Epstein JI
    Cancer; 1999 Dec; 86(11):2426-35. PubMed ID: 10590387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraoperative assessment of ovarian tumors: a 5-year review with assessment of discrepant diagnostic cases.
    Stewart CJ; Brennan BA; Hammond IG; Leung YC; McCartney AJ
    Int J Gynecol Pathol; 2006 Jul; 25(3):216-22. PubMed ID: 16810056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the least costly strategy to evaluate cervical abnormalities in rural women? Comparing telemedicine, local practitioners, and expert physicians.
    Bishai DM; Ferris DG; Litaker MS
    Med Decis Making; 2003; 23(6):463-70. PubMed ID: 14672106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of second-opinion diagnosis in oral and maxillofacial pathology.
    Jones K; Jordan RC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):865-9. PubMed ID: 20304686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of psammoma bodies on cervical cytology smears.
    Nicklin JL; Perrin L; Obermair A; McConachie I; Cominos D
    Gynecol Oncol; 2001 Oct; 83(1):6-9. PubMed ID: 11585407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virtual slide telepathology for an academic teaching hospital surgical pathology quality assurance program.
    Graham AR; Bhattacharyya AK; Scott KM; Lian F; Grasso LL; Richter LC; Carpenter JB; Chiang S; Henderson JT; Lopez AM; Barker GP; Weinstein RS
    Hum Pathol; 2009 Aug; 40(8):1129-36. PubMed ID: 19540562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?
    Smith EB; Frierson HF; Mills SE; Boyd JC; Theodorescu D
    Cancer; 2002 Apr; 94(8):2282-7. PubMed ID: 12001128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus detection: verification with cervical cytology.
    Matthews-Greer J; Rivette D; Reyes R; Vanderloos CF; Turbat-Herrera EA
    Clin Lab Sci; 2004; 17(1):8-11. PubMed ID: 15011974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact and frequency of anatomic pathology errors in cancer diagnoses.
    Raab SS; Grzybicki DM; Janosky JE; Zarbo RJ; Meier FA; Jensen C; Geyer SJ
    Cancer; 2005 Nov; 104(10):2205-13. PubMed ID: 16216029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the effect of pathology slide review on clinical practice in an oncology center].
    Emile JF; Di Palma M; Musset M; Sebagh M; Auriault ML; Misset JL; Reynès M
    Ann Pathol; 2000 Sep; 20(4):304-7. PubMed ID: 11015647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pap test discrepancies and follow-up histology.
    Stelow EB; Skeate R; Wahi MM; Kjeldahl K; McKeon D; Larkin S; Woronzoff K; Pambuccian SE
    Diagn Cytopathol; 2003 Aug; 29(2):111-5. PubMed ID: 12889052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative consultation in gynecologic pathology.
    Acs G
    Semin Diagn Pathol; 2002 Nov; 19(4):237-54. PubMed ID: 12469791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical redesign using all patient refined diagnosis related groups.
    Sedman AB; Bahl V; Bunting E; Bandy K; Jones S; Nasr SZ; Schulz K; Campbell DA
    Pediatrics; 2004 Oct; 114(4):965-9. PubMed ID: 15466092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National Cancer Data Base/Surveillance Epidemiology and End Results: potential insensitive-measure bias.
    Fanning J; Gangestad A; Andrews SJ
    Gynecol Oncol; 2000 Jun; 77(3):450-3. PubMed ID: 10831358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective.
    Kapali M; Agaram NP; Dabbs D; Kanbour A; White S; Austin RM
    Cancer; 2007 Feb; 111(1):26-33. PubMed ID: 17262796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telecytology: intraobserver and interobserver reproducibility in the diagnosis of cervical-vaginal smears.
    Alli PM; Ollayos CW; Thompson LD; Kapadia I; Butler DR; Williams BH; Rosenthal DL; O'leary TJ
    Hum Pathol; 2001 Dec; 32(12):1318-22. PubMed ID: 11774163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrepancies in dermatopathology diagnoses: the role of second review policies and dermatopathology fellowship training.
    Gaudi S; Zarandona JM; Raab SS; English JC; Jukic DM
    J Am Acad Dermatol; 2013 Jan; 68(1):119-28. PubMed ID: 22892284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
    Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
    Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical pathology sign-out. Routine review of every case by a second pathologist.
    Safrin RE; Bark CJ
    Am J Surg Pathol; 1993 Nov; 17(11):1190-2. PubMed ID: 8214266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.